Kolawole Olayinka Oyelese, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasa Previa | 13 | 2024 | 38 | 8.160 |
Why?
|
| Ultrasonography, Prenatal | 32 | 2024 | 1772 | 4.420 |
Why?
|
| Umbilical Cord | 13 | 2021 | 178 | 2.850 |
Why?
|
| Abruptio Placentae | 8 | 2014 | 116 | 1.390 |
Why?
|
| Pregnancy | 76 | 2024 | 30237 | 1.350 |
Why?
|
| Prenatal Diagnosis | 10 | 2023 | 1271 | 1.270 |
Why?
|
| Pregnancy, High-Risk | 5 | 2020 | 121 | 1.200 |
Why?
|
| Obstetrics | 4 | 2023 | 679 | 1.130 |
Why?
|
| Obstetric Labor, Premature | 5 | 2018 | 268 | 1.100 |
Why?
|
| Cerclage, Cervical | 3 | 2018 | 32 | 1.090 |
Why?
|
| Pregnancy Outcome | 14 | 2020 | 2971 | 1.050 |
Why?
|
| Placenta Previa | 5 | 2009 | 125 | 0.950 |
Why?
|
| Cesarean Section | 15 | 2023 | 1418 | 0.810 |
Why?
|
| Pregnancy Complications | 10 | 2020 | 2971 | 0.710 |
Why?
|
| Delivery, Obstetric | 6 | 2020 | 949 | 0.700 |
Why?
|
| Breech Presentation | 1 | 2020 | 40 | 0.690 |
Why?
|
| Postpartum Hemorrhage | 3 | 2010 | 275 | 0.680 |
Why?
|
| Delphi Technique | 1 | 2024 | 892 | 0.670 |
Why?
|
| Placenta | 8 | 2021 | 1725 | 0.670 |
Why?
|
| Placenta Diseases | 5 | 2012 | 199 | 0.660 |
Why?
|
| Amniotic Fluid | 3 | 2012 | 381 | 0.640 |
Why?
|
| Stillbirth | 5 | 2023 | 381 | 0.620 |
Why?
|
| Labor Presentation | 3 | 2004 | 54 | 0.610 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2018 | 24 | 0.600 |
Why?
|
| Gynecology | 2 | 2023 | 534 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2010 | 247 | 0.580 |
Why?
|
| Uterine Rupture | 3 | 2003 | 67 | 0.570 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 530 | 0.570 |
Why?
|
| Urogenital Abnormalities | 1 | 2020 | 255 | 0.560 |
Why?
|
| Trisomy | 2 | 2010 | 260 | 0.550 |
Why?
|
| Dehydration | 1 | 2018 | 216 | 0.540 |
Why?
|
| Uterus | 2 | 2020 | 661 | 0.540 |
Why?
|
| Fetal Diseases | 3 | 2014 | 915 | 0.520 |
Why?
|
| Gestational Age | 12 | 2022 | 3617 | 0.520 |
Why?
|
| Labor, Obstetric | 2 | 2020 | 313 | 0.520 |
Why?
|
| Cervical Length Measurement | 1 | 2015 | 47 | 0.480 |
Why?
|
| Fetomaternal Transfusion | 1 | 2014 | 10 | 0.470 |
Why?
|
| Pregnancy Trimester, Second | 5 | 2010 | 737 | 0.450 |
Why?
|
| Consensus | 1 | 2024 | 3208 | 0.450 |
Why?
|
| Perinatal Mortality | 1 | 2014 | 103 | 0.450 |
Why?
|
| Pre-Eclampsia | 3 | 2018 | 1256 | 0.420 |
Why?
|
| Female | 79 | 2024 | 396520 | 0.420 |
Why?
|
| Cervix Uteri | 6 | 2018 | 575 | 0.420 |
Why?
|
| Fetal Monitoring | 2 | 2011 | 69 | 0.400 |
Why?
|
| Creatinine | 1 | 2018 | 1917 | 0.400 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2020 | 2184 | 0.400 |
Why?
|
| Tocolytic Agents | 2 | 2003 | 24 | 0.390 |
Why?
|
| Fetus | 4 | 2022 | 1878 | 0.390 |
Why?
|
| Premature Birth | 5 | 2023 | 1830 | 0.380 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1241 | 0.380 |
Why?
|
| Parturition | 1 | 2015 | 453 | 0.370 |
Why?
|
| Directive Counseling | 1 | 2012 | 171 | 0.370 |
Why?
|
| Peer Review, Research | 1 | 2014 | 343 | 0.370 |
Why?
|
| Oligohydramnios | 3 | 2012 | 37 | 0.340 |
Why?
|
| Ultrasonography, Doppler, Color | 5 | 2006 | 234 | 0.340 |
Why?
|
| Umbilical Arteries | 3 | 2012 | 77 | 0.340 |
Why?
|
| Oxytocics | 3 | 2011 | 67 | 0.340 |
Why?
|
| Obstetric Labor Complications | 3 | 2008 | 240 | 0.330 |
Why?
|
| Editorial Policies | 1 | 2014 | 458 | 0.330 |
Why?
|
| Infant, Newborn | 19 | 2023 | 26389 | 0.320 |
Why?
|
| Humans | 81 | 2024 | 766766 | 0.300 |
Why?
|
| New Jersey | 5 | 2020 | 296 | 0.280 |
Why?
|
| Publishing | 1 | 2014 | 837 | 0.280 |
Why?
|
| Hemostatic Techniques | 1 | 2007 | 116 | 0.270 |
Why?
|
| Hysterectomy | 3 | 2008 | 863 | 0.270 |
Why?
|
| Meconium | 1 | 2006 | 47 | 0.270 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3232 | 0.250 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3110 | 0.250 |
Why?
|
| Amniocentesis | 1 | 2005 | 116 | 0.250 |
Why?
|
| Infant Mortality | 3 | 2005 | 751 | 0.250 |
Why?
|
| Adult | 45 | 2021 | 223307 | 0.250 |
Why?
|
| Erythrocytes | 1 | 2014 | 2412 | 0.240 |
Why?
|
| Terbutaline | 1 | 2003 | 26 | 0.210 |
Why?
|
| Twins | 1 | 2005 | 341 | 0.210 |
Why?
|
| Hypertension | 1 | 2023 | 8616 | 0.210 |
Why?
|
| Proteins | 1 | 2018 | 6002 | 0.210 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 1463 | 0.210 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2023 | 262 | 0.210 |
Why?
|
| Placenta Accreta | 1 | 2006 | 242 | 0.200 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2334 | 0.200 |
Why?
|
| Pregnancy, Ectopic | 1 | 2003 | 146 | 0.200 |
Why?
|
| Ovarian Cysts | 1 | 2002 | 107 | 0.200 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2014 | 519 | 0.190 |
Why?
|
| Ritodrine | 1 | 2000 | 4 | 0.180 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 3485 | 0.170 |
Why?
|
| Patient Discharge | 2 | 2013 | 3465 | 0.170 |
Why?
|
| Misoprostol | 1 | 2001 | 94 | 0.170 |
Why?
|
| Umbilical Veins | 1 | 2000 | 423 | 0.170 |
Why?
|
| Fetal Death | 2 | 1998 | 434 | 0.170 |
Why?
|
| Pelvic Neoplasms | 1 | 2002 | 249 | 0.170 |
Why?
|
| Retrospective Studies | 18 | 2022 | 81635 | 0.170 |
Why?
|
| Labor, Induced | 1 | 2001 | 153 | 0.170 |
Why?
|
| Pregnancy, Multiple | 1 | 2000 | 216 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3266 | 0.160 |
Why?
|
| Sampling Studies | 1 | 2020 | 614 | 0.160 |
Why?
|
| Communication | 1 | 2012 | 3905 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 746 | 0.150 |
Why?
|
| Focus Groups | 1 | 2024 | 1459 | 0.140 |
Why?
|
| Nitroglycerin | 1 | 1998 | 332 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2005 | 1158 | 0.140 |
Why?
|
| Risk | 2 | 2023 | 9602 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2002 | 644 | 0.140 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 12985 | 0.130 |
Why?
|
| Ultrasonography, Doppler | 3 | 2005 | 464 | 0.130 |
Why?
|
| Risk Factors | 16 | 2017 | 74881 | 0.130 |
Why?
|
| Outpatients | 1 | 2023 | 1596 | 0.130 |
Why?
|
| New England | 1 | 2018 | 1059 | 0.120 |
Why?
|
| Appendicitis | 1 | 2002 | 680 | 0.120 |
Why?
|
| Proteinuria | 1 | 2018 | 613 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2000 | 1111 | 0.120 |
Why?
|
| Tocolysis | 2 | 2006 | 18 | 0.120 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2007 | 137 | 0.120 |
Why?
|
| Fetal Growth Retardation | 1 | 1998 | 591 | 0.120 |
Why?
|
| Maternal Mortality | 1 | 2017 | 310 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2023 | 2141 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 988 | 0.110 |
Why?
|
| Australia | 1 | 2017 | 1263 | 0.110 |
Why?
|
| Progesterone | 1 | 2018 | 752 | 0.110 |
Why?
|
| Postmenopause | 1 | 2002 | 2517 | 0.110 |
Why?
|
| Incidence | 7 | 2023 | 21525 | 0.110 |
Why?
|
| False Negative Reactions | 1 | 2014 | 570 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1354 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 3721 | 0.100 |
Why?
|
| Fertilization in Vitro | 1 | 2000 | 1301 | 0.100 |
Why?
|
| Nuchal Cord | 1 | 2012 | 5 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1794 | 0.100 |
Why?
|
| Triplets | 2 | 2003 | 42 | 0.100 |
Why?
|
| Paternal Age | 1 | 2012 | 87 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1161 | 0.100 |
Why?
|
| Polyhydramnios | 1 | 2012 | 41 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10384 | 0.100 |
Why?
|
| Health Facilities | 1 | 2017 | 579 | 0.100 |
Why?
|
| Parity | 4 | 2013 | 931 | 0.100 |
Why?
|
| Fetal Movement | 1 | 2011 | 21 | 0.090 |
Why?
|
| Gravidity | 2 | 2008 | 50 | 0.090 |
Why?
|
| Fetal Distress | 1 | 2011 | 39 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2018 | 1195 | 0.090 |
Why?
|
| Liability, Legal | 1 | 2012 | 209 | 0.090 |
Why?
|
| Heart Rate, Fetal | 1 | 2011 | 77 | 0.090 |
Why?
|
| Uterine Contraction | 1 | 2011 | 90 | 0.090 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2727 | 0.090 |
Why?
|
| Biophysical Phenomena | 1 | 2011 | 318 | 0.090 |
Why?
|
| Consumer Health Information | 1 | 2012 | 215 | 0.080 |
Why?
|
| Cohort Studies | 9 | 2020 | 41710 | 0.080 |
Why?
|
| Patient Admission | 2 | 2014 | 1364 | 0.080 |
Why?
|
| Congenital Abnormalities | 2 | 2013 | 703 | 0.080 |
Why?
|
| Uterine Hemorrhage | 2 | 2008 | 235 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2010 | 957 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2023 | 8533 | 0.070 |
Why?
|
| Risk Assessment | 6 | 2020 | 24295 | 0.070 |
Why?
|
| Recurrence | 4 | 2010 | 8507 | 0.070 |
Why?
|
| Aspirin | 1 | 1998 | 3135 | 0.070 |
Why?
|
| Oxytocin | 1 | 2011 | 403 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1998 | 2763 | 0.070 |
Why?
|
| Natural Childbirth | 1 | 2006 | 15 | 0.070 |
Why?
|
| Maternal Age | 4 | 2013 | 804 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2011 | 36567 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2011 | 1260 | 0.060 |
Why?
|
| Informed Consent | 1 | 2012 | 1010 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2020 | 54871 | 0.060 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 141 | 0.060 |
Why?
|
| Balloon Occlusion | 1 | 2006 | 129 | 0.060 |
Why?
|
| Meningocele | 1 | 2005 | 50 | 0.060 |
Why?
|
| Young Adult | 6 | 2014 | 59939 | 0.060 |
Why?
|
| Prolapse | 1 | 2004 | 63 | 0.060 |
Why?
|
| Goiter | 1 | 2005 | 86 | 0.060 |
Why?
|
| Arteriovenous Malformations | 1 | 2007 | 396 | 0.060 |
Why?
|
| Hernia, Umbilical | 1 | 2005 | 102 | 0.060 |
Why?
|
| Down Syndrome | 1 | 2013 | 916 | 0.060 |
Why?
|
| Respiration Disorders | 1 | 2007 | 364 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2003 | 5182 | 0.060 |
Why?
|
| Thrombophilia | 1 | 2006 | 308 | 0.050 |
Why?
|
| Sacrum | 1 | 2005 | 273 | 0.050 |
Why?
|
| Pandemics | 2 | 2020 | 8735 | 0.050 |
Why?
|
| Patient Participation | 1 | 2012 | 1445 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2004 | 587 | 0.050 |
Why?
|
| Exercise Test | 1 | 2011 | 2188 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2009 | 1003 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2004 | 527 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15416 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 20144 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2693 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 2006 | 0.050 |
Why?
|
| Unnecessary Procedures | 1 | 2005 | 412 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1276 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 2478 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 684 | 0.050 |
Why?
|
| Rupture, Spontaneous | 1 | 2002 | 362 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 14652 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7871 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3692 | 0.040 |
Why?
|
| Decision Making | 1 | 2014 | 3951 | 0.040 |
Why?
|
| CA-125 Antigen | 1 | 2002 | 282 | 0.040 |
Why?
|
| Laparotomy | 1 | 2002 | 459 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 36461 | 0.040 |
Why?
|
| Fetal Development | 1 | 2005 | 777 | 0.040 |
Why?
|
| Physical Examination | 1 | 2006 | 1265 | 0.040 |
Why?
|
| Morbidity | 1 | 2005 | 1754 | 0.040 |
Why?
|
| Methotrexate | 1 | 2006 | 1719 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2013 | 5091 | 0.040 |
Why?
|
| Placental Circulation | 1 | 1998 | 37 | 0.040 |
Why?
|
| Placental Insufficiency | 1 | 1998 | 50 | 0.040 |
Why?
|
| Appendectomy | 1 | 2002 | 445 | 0.040 |
Why?
|
| Age Distribution | 3 | 2012 | 2869 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2011 | 5992 | 0.040 |
Why?
|
| Weight Gain | 1 | 2007 | 2356 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 588 | 0.030 |
Why?
|
| Cerebellum | 1 | 2004 | 1520 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 2228 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 1478 | 0.030 |
Why?
|
| Confidence Intervals | 3 | 2006 | 2921 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2005 | 2120 | 0.030 |
Why?
|
| United States | 6 | 2015 | 72951 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4853 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2003 | 4018 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 2020 | 2783 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5454 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2005 | 4047 | 0.030 |
Why?
|
| Resuscitation | 1 | 1999 | 681 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 858 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 223257 | 0.030 |
Why?
|
| Hospitals | 1 | 2005 | 3888 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2002 | 2039 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12064 | 0.020 |
Why?
|
| Male | 8 | 2020 | 364142 | 0.020 |
Why?
|
| Probability | 2 | 2006 | 2476 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2007 | 13050 | 0.020 |
Why?
|
| Prevalence | 2 | 2006 | 15835 | 0.020 |
Why?
|
| Hospitalization | 1 | 2009 | 10823 | 0.020 |
Why?
|
| Prognosis | 2 | 2013 | 29948 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2003 | 4056 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 6307 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15908 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 39309 | 0.020 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2008 | 187 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 5514 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 446 | 0.020 |
Why?
|
| Health Care Surveys | 2 | 2005 | 2425 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2007 | 382 | 0.020 |
Why?
|
| Cesarean Section, Repeat | 1 | 2006 | 32 | 0.020 |
Why?
|
| Decidua | 1 | 2006 | 80 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3620 | 0.020 |
Why?
|
| Propylthiouracil | 1 | 2005 | 68 | 0.020 |
Why?
|
| Antithyroid Agents | 1 | 2005 | 72 | 0.010 |
Why?
|
| Observer Variation | 1 | 2011 | 2614 | 0.010 |
Why?
|
| Pneumonia, Bacterial | 1 | 2007 | 319 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2007 | 634 | 0.010 |
Why?
|
| District of Columbia | 1 | 2003 | 159 | 0.010 |
Why?
|
| Mathematics | 1 | 2004 | 696 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40149 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 574 | 0.010 |
Why?
|
| Arteries | 1 | 2008 | 1123 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 2005 | 292 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2005 | 453 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2007 | 9357 | 0.010 |
Why?
|
| Thyroxine | 1 | 2005 | 665 | 0.010 |
Why?
|
| Registries | 2 | 2007 | 8351 | 0.010 |
Why?
|
| Adolescent | 4 | 2013 | 88904 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 65273 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2009 | 22248 | 0.010 |
Why?
|
| Family | 1 | 2009 | 3209 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 2005 | 1170 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 1408 | 0.010 |
Why?
|
| Reoperation | 1 | 2008 | 4325 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7241 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2446 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 6207 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2008 | 3799 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 13278 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 14762 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 10860 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15831 | 0.000 |
Why?
|
| Obesity | 1 | 2007 | 13090 | 0.000 |
Why?
|